Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The THF-II riboswitch is a conserved non-coding RNA structure found typically in the 5’ untranslated regions of bacterial mRNAs, where it regulates gene expression in response to binding tetrahydrofolic acid (THF) and closely related metabolites[1][3][4][5][6]. It adopts a simple, rod-like secondary and tertiary structure, with aptamer and expression platform regions largely overlapping, and recognizes THF via highly specific nucleotide-ligand contacts[1][3]. Ligand binding stabilizes specific local RNA conformations (notably in loop regions), promoting the formation of an anti-ribosome binding site (anti-RBS) stem that inhibits ribosome access, thereby shutting off translation[1][3][4]. While THF-II riboswitches have been proposed as potential novel antibiotic targets due to their bacterial specificity and essential regulatory role for folate-related metabolism, no drugs are currently approved to target them directly[4]. The THF-II riboswitch is distinct from the structurally related THF-I riboswitch, notably in its simpler architecture and more restricted ligand specificity[3][1].
Ligand binding (tetrahydrofolate or close analogs) induces a conformational switch that represses translation by preventing ribosome binding to the mRNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on THF-II riboswitch.